SAN FRANCISCO, December 1, 2017 /PRNewswire/ -- Recapitalization plan to use funding mechanisms created under the JOBS Act Elto Pharma, Inc. preparing to re-start Eltoprazine Phase 2b PD-LID clinical trial Cutanogen Corporation focusing on identifying new c...
Press Release
|